integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
GPYKJDYMMUIUFG-UHFFFAOYSA-N
1-(2-Furanyl)-1,3-butanedione
1-(uran-2-yl)butane-1,3-dione
GPYKJDYMMUIUFG-UHFFFAOYSA-N
CHEBI:173651
0 Reactome links
2 studies
2
Observed studies
2
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
GPYKJDYMMUIUFG-UHFFFAOYSA-N
InChI Key
GPYKJDYMMUIUFG-UHFFFAOYSA-N
IUPAC name
1-(uran-2-yl)butane-1,3-dione
Preferred name
1-(2-Furanyl)-1,3-butanedione
INN name
—
Synonym
—
ChEBI
CHEBI:173651
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
Observed in differential profiles
G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h